# Orbital Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orbital-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.orbitaltx.com
- Total disclosed funding: $320M
- Latest round: Series A (Mar 9, 2023)
- Investors on record: 14

## About

Based in the US, and co-founded by Giuseppe Ciaramella (CEO), Kristina Burow, and Carol Suh, in 2022, Orbital Therapeutics is a biotechnology research company working on the enhancement of global health by unleashing the full potential of RNA-based medicines. In April 2023, Orbital Therapeutics raised USD 270 million in series A funding led by returning investor ARCH Venture Partners, with participation from other returning investors Andreessen Horowitz and Newpath Partners. New investors Abu Dhabi Growth Fund, Agent Capital, Alexandria Venture Investments, Casdin Capital, EXOR, Heritage Medical Systems, iGlobe Partners, Invus, Moore Strategic Ventures, Redmile Group, Rellim Capital Management, and other unspecified investors also participated in the round.
The company is working on building a platform that integrates and applies established and emerging technologies across RNA delivery methods excluding RNAi therapeutics, data science, and automation to develop medicines focused in the areas of vaccines, immunomodulation, protein replacement, and regenerative medicine and hence treat human diseases.

## Funding rounds

- Series A, Mar 9, 2023, $270M — ARCH Venture Partners, Alexandria Venture Investments, iGlobe Partners, EXOR, Invus [DUP], Andreessen Horowitz, Redmile Group, Casdin Capital, Agent Capital, Moore Strategic Ventures, Newpath Partners, Heritage Medical Systems, Abu Dhabi Growth Fund, Rellim Capital Management
- Seed, Aug 16, 2022, $50M — ARCH Venture Partners, Andreessen Horowitz, Newpath Partners

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Seed, Series A
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Seed, Series A
- Newpath Partners (https://capitalatlas.ai/funds/newpath-partners) — Seed, Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- iGlobe Partners (https://capitalatlas.ai/funds/iglobe-partners) — Series A
- EXOR — Series A
- Invus [DUP] — Series A
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series A
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series A
- Agent Capital (https://capitalatlas.ai/funds/agent-capital) — Series A
- Moore Strategic Ventures (https://capitalatlas.ai/funds/moore-strategic-ventures) — Series A
- Heritage Medical Systems — Series A
- Abu Dhabi Growth Fund — Series A
- Rellim Capital Management — Series A